Big things are happening at Tiger Aesthetics Medical, LLC.
Industry vet Caroline (Caro) Van Hove is the new President and will oversee all U.S. Commercial Operations and Product Distribution.
Van Hove previously held the position as CEO for Revelle Aesthetics, leading Revelle through the start-up phase to a successful acquisition by Tiger Aesthetics in 2024. Van Hove has more than two decades of experience in medical aesthetics and significant change management expertise.
“I am honored to take on this role at such a pivotal time for Tiger Aesthetics,” says Caro Van Hove, President of Tiger Aesthetics, in a news release. “Our next phase of growth will be transformative for the industry as we look to create a new category comprised of structural adipose tissue products and a head-to-toe portfolio of diverse treatment options for patients and practices. Our goal is to create lasting value for our customers and I’m confident that our strong foundation and team will deliver great results.”
In addition, the Company invested $50 million into its manufacturing operations with the construction of a new facility in Franklin, WI to support its breast augmentation and reconstruction business.
New technologies and processes will be implemented that will allow Tiger to manufacture its portfolio at increased scale and greater efficiency. Alongside Tiger BioSciences’ locations in California, Texas, Pennsylvania and North Carolina, the new Wisconsin facility will further enhance Tiger’s vertical integration. The Company anticipates the new facility will lead to a doubling of its existing workforce by 2028.
